The mouse dystrophin gene enhancer requires E-boxes 1, 2, and 3 and the serum response element for activity, with MyoD binding at E1 and E3 in myotubes.
The study identifies key regulatory elements and transcription factors, including MyoD and serum response factor, that control the activity of the mouse dystrophin gene enhancer.
In vivo studies in the mouse have revealed that the muscle promoter of the mouse dystrophin gene can target the right ventricle of the heart only, suggesting the need for other regulatory elements to target the skeletal muscle as well as other compartments of the heart. In this study we report the identification of the mouse dystrophin gene enhancer that is located approximately 8.5 kilobases downstream from the mouse dystrophin gene muscle promoter. The enhancer was tested in myogenic G8, H9-C2, and nonmyogenic 3T3 cell lines and is mostly active in G8 myotubes. Sequence analysis of the mouse dystrophin gene enhancer revealed the presence of four E-boxes numbered E1-E4, a putative mef-2 binding site, and a serum response element. Site-directed mutagenesis studies have shown that E-boxes 1, 2, and 3 as well as the serum response element are required for enhancer activity. Gel shift analysis revealed two binding activities at binding sites E1 and E3 which were specific to myotubes, and supershift assays confirmed that myoD binds at both these sites. Our study also shows that werum response factor binds the serum response element but in myoblasts and fibroblasts only, suggesting that serum response factor may repress enhancer function.
Marshall et al. (Mon,) reported a other. The mouse dystrophin gene enhancer requires E-boxes 1, 2, and 3 and the serum response element for activity, with MyoD binding at E1 and E3 in myotubes.